Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #10year--Bristol Myers Squibb Presents Landmark 10-Year Follow-Up Data from CheckMate -067 Which Showed Continued Durable Long-Term Survival Benefit.
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
08:45am, Saturday, 14'th Sep 2024
Bristol Myers Squibb and Gilead Sciences are longtime healthcare leaders. Both have the innovative abilities needed to continue developing new drugs.
Bristol Myers Stock Rises 16% in 3 Months: Buy, Sell or Hold?
02:40pm, Wednesday, 11'th Sep 2024
BMY's recent rally gives investors a ray of hope after the downturn earlier on in 2024. However, we advise investors not to be over-optimistic at this point and look before they leap.
Bristol Myers Squibb Announces Dividend
05:45pm, Tuesday, 10'th Sep 2024
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Dividend.
Bristol Myers Squibb Dividend Yield Pushes Past 5%
03:51pm, Monday, 09'th Sep 2024
In trading on Monday, shares of Bristol Myers Squibb were yielding above the 5% mark based on its quarterly dividend (annualized to $2.4), with the stock changing hands as low as $47.55 on the day. Di
Bristol Myers Squibb: Momentum Still Promising Through H2 2024, Turnaround Likely Prolonged
11:00am, Monday, 09'th Sep 2024
BMY's rally from the July 2024 bottom is well deserved, as the market rotated from high growth to high dividend-yielding sectors. This is significantly aided by the pharmaceutical company's robust FQ2
2 Unstoppable Dividend Growth Stocks You Can Buy Now With $100
04:56am, Sunday, 08'th Sep 2024
A bear market could be around the corner, but it probably won't stop Bristol Myers Squibb and Royalty Pharma from rapidly raising their dividend payouts. Bristol Myers Squibb has increased its dividen
Bristol-Myers Squibb: A Better Earnings Outlook, Stronger Momentum Heading Into 2025
05:08pm, Friday, 06'th Sep 2024
Bristol-Myers Squibb delivered a significant earnings beat in Q2, driving shares up 20% since spring and boosting sector performance. Despite concerns about long-term EPS, strong Q2 results and improv
Bristol-Myers Squibb Company (BMY) Wells Fargo 2024 Healthcare Conference (Transcript)
01:04pm, Friday, 06'th Sep 2024
Bristol-Myers Squibb Company (NYSE:BMY ) Wells Fargo 2024 Healthcare Conference September 6, 2024 12:00 AM ET Company Participants Adam Lenkowsky - Chief Commercialization Officer Conference Call Part
Bristol-Myers Still A Value Play Despite Appreciating 26.56% From 2024 Lows
09:00am, Friday, 06'th Sep 2024
BMY has appreciated 26.56% since July but remains undervalued with a 4.8% yield, trading at less than 8 times 2025 earnings. Q2 earnings validated my thesis with a $680 million revenue beat and a $6.4
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 mln valuation in US IPO
06:59am, Friday, 06'th Sep 2024
Zenas BioPharma, which is developing immunology-based therapies, said on Friday it is targeting a valuation of as much as $689.7 million in its initial public offering in the United States.
Pharma stocks analysis: Pfizer, Bristol-Myers Squibb, AbbVie
04:00am, Friday, 06'th Sep 2024
Pharmaceutical (PPH) stocks have done relatively well this year. The closely watched iShares US Pharmaceutical ETF (IHE) stock has jumped by 16.5%, slightly beating the S&P 500 index, which has risen
Bristol Myers Squibb (BMY) Falls More Steeply Than Broader Market: What Investors Need to Know
06:51pm, Thursday, 05'th Sep 2024
Bristol Myers Squibb (BMY) closed at $49.80 in the latest trading session, marking a -0.32% move from the prior day.
Bristol-Myers Squibb Company (BMY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
03:33pm, Thursday, 05'th Sep 2024
Bristol-Myers Squibb Company (NYSE:BMY ) Morgan Stanley 22nd Annual Global Healthcare Conference September 5, 2024 1:05 PM ET Company Participants Chris Boerner - Chief Executive Officer David Elkins
Final Trade: BMY, C, .BKX & TXT
06:48pm, Tuesday, 03'rd Sep 2024
The final trades of the day with the Fast Money traders.
